Abbvie Inc
NYSE: ABBV
$179.17
+$2.22 (+1.3%)
Real Time Data Delayed 15 Min.
ABBV Articles
Now all investor eyes turn to first-quarter earnings results. With interest rates still very low, investors looking to add capital should still focus on top dividend-paying stocks.
Published:
Last Updated:
Long-term growth investors looking for a degree of safety and value should consider some of these outstanding companies. While the sentiment may be less than stellar now, massive drug pricing changes...
Published:
Last Updated:
For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made a couple additions and updated its price target information.
Published:
Last Updated:
The February 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest decreased.
Published:
Last Updated:
In a recent research report, Jefferiesfocused on some large cap stocks that are still trading way below their 52-week highs.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen from Monday, March 7, include Enbridge, Micron Technology, Sun Life Financial, Starbucks, Stratasys and Wynn Resorts.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen from Friday, February 26, include American Water Works, Autodesk, Kraft Heinz, Palo Alto Networks, Toyota and Vipshop.
Published:
Last Updated:
The February 12 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest increased.
Published:
Last Updated:
These stocks make good sense for long-term patient investors that have a growth and income total return bias in their portfolios.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday, February 23, include Annaly Capital Management, Barrick Gold, Cheniere Energy, Fitbit, Dean Foods, Groupon, SolarCity, Twitter...
Published:
Last Updated:
In a new research report, Jefferies shuffles some of the pharmaceutical stocks in its coverage universe and a beaten-down dividend leader is now the top pick globally.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday, February 22, include AbbVie, Deere, Expedia, Hewlett Packard Enterprise, JPMorgan and Phillips 66.
Published:
Last Updated:
For worried investors that need an income stream, all these top stocks make good sense for growth and income portfolios.
Published:
Last Updated:
One thing that the recent sell-off has accomplished is to take top companies residing in the Jefferies Franchise Picks list to levels not seen in some time.
Published:
Last Updated:
The January 29 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest increased.
Published:
Last Updated: